b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30784939</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>08</Month>\n            <Day>08</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>08</Month>\n            <Day>08</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1950-6007</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>112</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Apr</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>\n                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>108670</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)30225-2</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.108670</ELocationID>\n            <Abstract>\n                <AbstractText>Glucagon-like peptide-1 (GLP-1) an incretin hormone, is known to regulate the glucose-mediated insulin secretion. However, reduction in the level of GLP-1 is considered to be a major cause for the reduction of GLP-1-dependent insulin secretory response. Genistein an isoflavone, is an important polyphenol and has wide range of therapeutic potentials, but its therapeutic effects alone and/or in combination with metformin on GLP-1 secretion have not been investigated yet. Hence, we aimed to investigate the stimulatory action of genistein in combination with metformin on GLP-1 via downregulation of inflammatory mediators, hyperlipidemia and hyperglycemia in alloxan-induced diabetic rats. Diabetes was induced in experimental rats by single administration of alloxan intraperitoneally. Metformin (50\xe2\x80\x89mg/kg/day), genistein (20\xe2\x80\x89mg/kg/day) and combination of genistein and metformin was administered in alloxan-induced diabetic rats. We found that genistein alone and/or in combination with metformin significantly increased the serum level (P\xe2\x80\x89&lt;\xe2\x80\x890.01) and tissue content (P\xe2\x80\x89&lt;\xe2\x80\x890.05) of GLP-1 in intestine when compared with that of metformin-treated animals. Similarly, genistein alone and/or in combination with metformin also resulted in normoglycemia (P\xe2\x80\x89&lt;\xe2\x80\x890.001), glucose tolerance (P\xe2\x80\x89&lt;\xe2\x80\x890.01), insulin sensitivity (P\xe2\x80\x89&lt;\xe2\x80\x890.0001), hyperlipidemia (P\xe2\x80\x89&lt;\xe2\x80\x890.01), liver and kidney function biomarkers (P\xe2\x80\x89&lt;\xe2\x80\x890.01) as compared to that of metformin-treated experimental animals. Moreover, genistein alone and/or in combination with metformin also downregulated the inflammatory responses by decreasing the levels of interleuin-6, tumor necrosis factor-\xce\xb1 and C-reactive protein in serum (P\xe2\x80\x89&lt;\xe2\x80\x890.05) and intestine (P\xe2\x80\x89&lt;\xe2\x80\x890.001) more efficiently as compared to that of metformin-treated experimental animals. The downregulation of inflammatory responses in intestine, was positively associated with increased secretion of GLP-1 from intestine. Histopathology of pancreas and intestine also showed that genistein significantly improved the deleterious effects of alloxan on pancreas and intestine. Hence, our work provides new insights on the synergistic effects of genistein and metformin on GLP-1 secretion. This may significantly improve the perception for proposing new GLP-1-based synergistic approaches for the treatment of diabetes mellitus.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Rehman</LastName>\n                    <ForeName>Kanwal</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ali</LastName>\n                    <ForeName>Mehwish Bagh</ForeName>\n                    <Initials>MB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Akash</LastName>\n                    <ForeName>Muhammad Sajid Hamid</ForeName>\n                    <Initials>MSH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan. Electronic address: sajidakash@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>20</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>France</Country>\n            <MedlineTA>Biomed Pharmacother</MedlineTA>\n            <NlmUniqueID>8213295</NlmUniqueID>\n            <ISSNLinking>0753-3322</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>89750-14-1</RegistryNumber>\n                <NameOfSubstance UI="D052216">Glucagon-Like Peptide 1</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>DH2M523P0H</RegistryNumber>\n                <NameOfSubstance UI="D019833">Genistein</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019833" MajorTopicYN="N">Genistein</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D052216" MajorTopicYN="N">Glucagon-Like Peptide 1</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Diabetes mellitus</Keyword>\n            <Keyword MajorTopicYN="N">GLP-1</Keyword>\n            <Keyword MajorTopicYN="N">Genistein</Keyword>\n            <Keyword MajorTopicYN="N">Incretin hormone</Keyword>\n            <Keyword MajorTopicYN="N">Inflammatory responses</Keyword>\n            <Keyword MajorTopicYN="N">Metformin</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>31</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>9</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30784939</ArticleId>\n            <ArticleId IdType="pii">S0753-3322(19)30225-2</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.biopha.2019.108670</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'